Across all breast cancer subtypes examined, at least a positive two-fold increase (with a corresponding P-value < 0.05) was observed in KPNA2 mRNA expression levels between healthy and breast cancer tissue, indicating KPNA2 overexpression across various breast cancer types. Here, KPNA2 is linked to breast carcinoma.